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Abstract 
Objective: Prove that conducting complementary studies at laboratories and imaging studies 
are unnecessary in irst-time unprovoked seizures, since there is no change in the evolution and 
prognosis of the disease, as well as the study of our population, the incidence rate and the pro-
portion of our patients that have been studied and given maintenance treatment, so it can be 
determined whether or not our population should follow the suggestions of the American 
Academy of Pediatrics and the Spanish Pediatric Association.
Methods: An observational study, including patients diagnosed with irst-time unprovoked seizu-
res. They were followed up on by the emergency department and information was collected 
from their clinical history and compared with the results of the different studies between pa-
tients that suffered just one seizure and the ones that had recurrent seizures. 
Results: Thirty one patients were included, 14 males and 17 females. The average age was 5.5 
years old. The 100% of patients were studied, and the groups were compared. The signiicant 
study was the electroencephalogram (EEG) with a p=0.02 (signiicance p<0.05), incidence of 
41%. 
Conclusions: The study and diagnosis of irst-time unprovoked seizures is based on clinical ma-
nifestations. The EEG is important in the study and classiication of unprovoked seizures. Our 
population has an incidence and recurrence rate similar to that in the bibliography, and for that 
reason, this study suggests that the diagnostic and therapeutic guidelines of the American Aca-
demy of Pediatrics and the Spanish Pediatric Association should be followed.
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Introduction
About 5% of the patients who arrive at the emergency room 
are admitted with a seizure diagnosis.1 Management of the-
se patients is determined by the irst-contact pediatrician; 
they decide whether or not the patient gets exams/tests, is 
admitted and begins treatment.1 There is no standardized 
algorithm for the initial assessment of a patient who had a 
seizure for the irst time, therefore a thorough case history 
and physical examination are required in order to determi-
ne additional lab and neuroimaging testing.2 Academic 
groups like the American and European Pediatrics Associa-
tion suggest that neither additional testing or medical ad-
mittance are necessary for patients who had generalized 
unprovoked seizures.3
Currently we do not have studies describing our popula-
tion; therefore we must follow the recommendations and 
guidelines given by these academic groups; for this reason 
we are conducting this research. Our main objective is to 
prove there is no need for additional lab and neuroimaging 
testing for patients who had generalized unprovoked seizu-
res because it does not modify management, evolution or 
prognosis. Moreover, as speciic objectives we will study the 
following: irst-time generalized unprovoked seizure inci-
dence at the “Dr. José Eleuterio González” University Hos-
pital, percentage of patients who get additional procedures 
and/or additional studies, costs and length of hospital stays, 
the number of patients discharged with anti-seizure 
treatment and the most utilized anti-seizure in an acute 
event and subsequent to the event.
Methods
We designed an observational, descriptive, logitudinal, non-
blind, prospective study.
We included in our population, patients of the “Dr. José 
Eleuterio González” University Hospital. We calculated the 
sample size using the inite population formula, with a re-
sult of 25 patients who had a irst-time unprovoked seizure 
incidence in order to have signiicant results. This study was 
conducted over a period of 2 years; therefore we were able 
to include a total of 31 patients. We followed the patients 
during their medical visit and during their first follow- 
up appointment within the first month. The study and 
treatment was determined by the on-call doctor in the Pe-
diatric Emergency Room at the University Hospital. We as 
researchers did not intervene in the decision making pro-
cess. We obtained the information from their clinical iles, 
gathering the following variables: age, gender, family his-
tory, perinatal history, use and type of anti-seizure in the 
acute event and subsequent to it and if they had studies 
performed, like a complete blood count (CBC), basic meta-
bolic panel (BMP), lumbar puncture, electroencephalogram 
(EEg), computed tomography (CT) and magnetic resonance 
(MRI). The variables were compiled in a database created 
using Microsoft Excel®, later to be analyzed using statistical 
software SPSS® Statistics v. 20.0. Continuous variables will 
be expressed in median and standard deviation (SD) or ran-
ges, on the other hand categorical variables will be descri-
bed in percentages.
We included patients ranging from 6 months to 16 years 
old, with a irst-time seizure diagnosis, generalized, unpro-
voked, about 5 minutes long, without focalization data after 
the event, with a normal neurological exam. We excluded 
patients with provoked seizures, history of previous seizu-
res, patients with an epilepsy diagnosis, psychomotor deve-
lopment alterations, a previous brain injury, intoxication, 
gastrointestinal problems, vomiting and diarrhea, patients 
with dehydration data or central nervous system infection 
data and patients with an abnormal neurological explora-
tion.
We divided the patients into 2 groups, patients who dis-
played recurrence in one group, and those who did not in 
the other group. We compared their lab and clinical tests’ 
results to verify that they were not anticipating immediate 
seizure evolution and/or complications. We deined imme-
diate complications to the recurrence of seizures within the 
first month. We also divided the patients who received 
treatment from those who did not, in order to assess recu-
rrence.
Results
Our sample size required a minimum of 25 patients; howe-
ver, we managed to include 31 patients who met the inclu-
sion criteria. We had 14 males and 17 females, with a 
median age of 5.5 years of age. Out of the 31 patients, the-
re were 7 (22.6%) with a family history and 24 (77.4%) 
without, 3 (9.7%) had perinatal history and 28 (90.3%) did 
not.
We studied 31 patients as follows: We performed a lumbar 
puncture in 5 of them (0 abnormalities reported), 24 BMP (0 
alterations), 26 CBC (2 altered results) and 24 neuroimaging 
scans (CT and MRI) with one altered result which was repor-
ted as a inding without being a cause of seizure. We perfor-
med an EEg in all 31 of the patients of which 14 were 
reported abnormal.
We compared the different test results from patients who 
experienced a recurrent episode to those patients who did 
not experience one, to verify if the results of the studies 
change or predict recurrences; of these the only one who 
showed signiicant results was p=0.02 the EEg (Table 1).
Out of the 31 patients who went to the emergency room, 
we began anticonvulsant treatment in 19 patients. Twelve 
patients were discharged conservatively, without anti-seizu-
re treatment. Out of the 19 patients, 14 were given phen-
ytoin, and 5 patients were given valproic acid.
We compared seizure recurrence in patients discharged 
with treatment to those patients discharged without it, 
which showed a non-signiicant result with p=0.69, with an 
Odds Ratio (OR) of 0.55 and a conidence interval (CI) of 
0.12-2.49, showing that the indication of chronic treatment 
is not a factor in protecting the patient against seizure re-
currence (Table 2).
We researched inpatient costs and length, which resulted 
in a median of 1.5 days for the full study of seizures in pa-
tients who were admitted to the hospital. The costs are re-
ported in Table 3. 
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Discussion 
The results of the study were not very distant from those 
found in medical literature. With a similar reported inci-
dence4 of 4 seizure episodes for every 1,000 habitants, 
which are said to be overstudied. This population was stu-
died in full with at least one lab and/or clinical test, sepa-
rating the EEg. Laboratory and neuroimaging tests were 
performed in 77% of the patients. None of them were re-
ported with signiicant results for the diagnosis and prog-
nosis of the disease, only the EEG had a signiicant p lower 
than 0.5, p=0.02.
Out of the 31 patients who had seizures, 45% showed an 
abnormal EEg, and from these patients with electroen-
cephalographic alterations, 64% suffered a recurrence, 
compared to the rate reported in publications, which refers 
to a recurrence rate of 71%.4
The results regarding the recurrence of seizures treated 
with anti-seizure medication were similar to the data pu-
blished. We prescribed treatment to 61% of the population. 
Of the patients who received treatment, 47% had a recu-
rrence (29% of the entire population); this data can be com-
pared to medical literature which mentions a probability of 
recurrence in a year of 19% to 26%. In this case the period of 
time is a variable, whereas in our study we just monitored 
the patients up to the irst follow-up visit which is in a pe-
riod of time no longer than 30 days.
This population showed a recurrence rate of 41% of the 
patients in the follow-up visit, compared with 3 other stu-
dies which recorded the recurrence rate at 2 years: 37%,5 
54% (95% CI=46%-62%)6 and 57%, respectively.7
Conclusion
First-time seizure study and diagnosis is based on the clini-
cal study. EEG plays a major role in the study and classiica-
tion of unprovoked seizures. The use of medications and 
anti-seizure therapy after an unprovoked seizure is contro-
versial; therefore each case should be personalized. The 
doctor should adequately study recurrence risk factors in 
order to start the patient on maintenance medication and 
compare the beneits with the medication’s adverse effects. 
Our population has similar incidence and recurrence rates 
to those reported in the references, thus this study suggests 
following the guidelines and recommendations made by the 
American and European Pediatrics Association concerning 
irst-time unprovoked seizures.
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Table 1 Comparison of laboratory results.
Laboratory Had seizure
  Yes No Total p
HB
Normal
Abnormal 
Not taken
12
0
1
12
2
4
24
2
5
0.21
BC and SE
Normal
Abnormal
Not taken
11
0
2
13
0
5
24
0
7
0.45
EEg
Normal
Abnormal
Not taken
4
9
0
13
5
0
17
14
0
0.02
Neuroimaging
Normal
Abnormal
Not taken
12
0
1
11
1
6
24
1
7
0.14
Lumbar 
puncture
Normal
Abnormal
Not taken
1
0
12
4
0
14
5
0
26
0.06
HB: hematic biometry; BC: blood chemistry; SE: serum 
electrolytes; EEg: electroencephalogram. 
Source: “Dr. José Eleuterio González” University Hospital of 
the Universidad Autónoma de Nuevo León, 2012-2013.
Table 2 Treatment and recurrence of seizures.
Treatment Seizure recurrence
 Yes No Total p OR 95% CI
Yes 9 (47%) 10 (52%) 19
No 4 (33%) 8 (66%) 12
Total 13 18 31 0.69 0.55
0.12-
2.49
OR: Odd Ratio; CI: conidence interval. 
Source: “Dr. José Eleuterio González” University Hospital of 
the Universidad Autónoma de Nuevo León, 2012-2013.
Table 3 Costs.
Study Cost Number Total cost
MRI 4,400 14 61,600
CT 2,759 10 27,500
EEg 1,150 31 48,050
MXN Peso MXN Peso
MRI: magnetic resonance; CT: computed tomography; EEg: 
electroencephalogram; MXN: Mexican peso. 
Source: “Dr. José Eleuterio González” University Hospital of 
the Universidad Autónoma de Nuevo León, 2012-2013.
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